Filing Details

Accession Number:
0001209191-19-032020
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-22 15:43:28
Reporting Period:
2019-05-20
Accepted Time:
2019-05-22 15:43:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885978 U S Physical Therapy Inc USPH Services-Health Services (8000) 760364866
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1270356 J Christopher Reading 1300 W. Sam Houston Pkwy S.
Suite 300
Houston TX 77042
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-05-20 10,000 $118.22 78,918 No 4 S Direct
Common Stock Disposition 2019-05-21 9,860 $120.52 69,058 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.00 to $118.60 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  2. Includes 44,509 shares which restrictions lapse as to 4,984 shares on each of July 1, 2019, October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023.
  3. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.00 to $120.91 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.